1
|
Vega J, Carrasco A, Karim N, Stewart M, Bell W. Recurrent cerebellar ischemic infarctions and stereotyped peri-ictal sympathetic responses in a near-SUDEP patient with cardiovascular risk factors. Epilepsy Behav Rep 2023; 23:100605. [PMID: 37332897 PMCID: PMC10276251 DOI: 10.1016/j.ebr.2023.100605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 05/02/2023] [Accepted: 05/04/2023] [Indexed: 06/20/2023] Open
Abstract
We report a 60-year-old woman who presented to the emergency department after experiencing a witnessed unknown onset bilateral tonic clonic seizure (GTCS) that culminated in cardiac arrest. A neurology consultant uncovered a years-long history of frequent episodic staring followed by confusion and expressive aphasia, which strongly suggested that she suffered from epilepsy. Thus, her cardiac arrest and subsequent resuscitation met criteria for a near-sudden unexpected death in epilepsy (SUDEP) diagnosis. Serial bloodwork demonstrated transient troponin I elevations and leukocytoses, while a brain MRI revealed global cerebral anoxic injury and a small acute right cerebellar ischemic infarction. A review of her medical record uncovered a hospitalization sixteen months earlier for a likely GTCS whose workup showed similar troponin I elevations and leukocytoses, and surprisingly, a different small acute right cerebellar ischemic infarction in the same vascular territory. To our knowledge, this is the first report of subcortical ischemic infarctions occurring concurrently with GTCSs in a near-SUDEP patient. Aside from illustrating the key role of inpatient neurologists in the diagnosis of near-SUDEP, this manuscript discusses the potential significance of postictal ischemic infarctions, transient asymptomatic troponin elevations, and transient non-infectious leukocytoses in epilepsy patients with cardiovascular risk factors.
Collapse
Affiliation(s)
- J.L. Vega
- East Carolina University Medical Center, Greenville, NC, United States
- TeleNeurologia SAS, Medellin, Colombia
| | - A. Carrasco
- Brody School of Medicine, East Carolina University, Greenville, NC, United States
| | - N. Karim
- East Carolina University Medical Center, Greenville, NC, United States
| | - M. Stewart
- Departments of Neurology, State University of New York Health Sciences University, Brooklyn, NY, United States
- Physiology and Pharmacology, State University of New York Health Sciences University, Brooklyn, NY, United States
| | - W. Bell
- Brody School of Medicine, East Carolina University, Greenville, NC, United States
| |
Collapse
|
2
|
Bell W, Colley J, Evans W, Darlington S, Cooper SM. ACTN3 genotypes of Rugby Union players: Distribution, power output and body composition. Ann Hum Biol 2011; 39:19-27. [DOI: 10.3109/03014460.2011.632648] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
3
|
Petkar S, Bell W, Rice N, Iddon P, Cooper P, McKee D, Curtis N, Hanley M, Stuart J, Mackway Jones K, Fitzpatrick AP. Initial experience with a rapid access blackouts triage clinic. Clin Med (Lond) 2011; 11:11-6. [PMID: 21404775 PMCID: PMC5873791 DOI: 10.7861/clinmedicine.11-1-11] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Transient loss of consciousness (T-LOC), or blackout, is common in acute medicine. Clinical skills are not done well, with at least 74,000 patients misdiagnosed and mistreated for epilepsy in England alone. The aim of this study was to provide a rapid, structured assessment and an electrocardiogram (ECG) for patients with blackouts, aiming to identify high risk, reduce misdiagnoses, reduce hospital admission rates for low-risk patients, diagnose and treat where appropriate, and also provide onward specialist referral. The majority of patients had syncope, and very few had epilepsy. A high proportion had an abnormal ECG. A specialist-nurse-led rapid access blackouts triage clinic (RABTC) provided rapid effective triage for risk, a comprehensive assessment format, direct treatment for many patients, and otherwise a prompt appropriate onward referral. Rapid assessment through a RABTC reduced re-admissions with blackouts. Widespread use of the web-based blackouts tool could provide the NHS with a performance map. The U.K. has low rates of pacing compared to Western Europe, which RABTCs might help correct. The RABTC sits between first responders and specialist referral, providing clinical assessment and ECG in all cases, and referral where appropriate.
Collapse
Affiliation(s)
- S Petkar
- Central Manchester Foundation Hospital Trust
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Abstract
The purpose of the present study was to analyse the dynamics of distance, velocity and acceleration of the 30-s Wingate Anaerobic Test. Participants were 53 young adult Rugby Union football players of mean age 21.6±2.5 yr, 180.5±7.2 cm height and 89.3±12.7 kg body mass. Measurements of power were obtained using a friction-belt cycle ergometer (Monark 864, Varberg, Sweden). Individual data were aligned according to peak power output, which resulted in a mean value of 1 216±256 W, compared with one of 1 180±256 W when calculated cross-sectionally (p<0.0001). The derivatives of velocity and acceleration were obtained using the mathematical software Mathcad. Distance, velocity and acceleration curves were plotted simultaneously at 1 s intervals before and after peak power output (-4 s to +28 s). The initial rise of the distance curve was the result of a general trend in decreasing positive velocities as far as peak power output, followed thereafter by a gradual deterioration of power, the result of negative velocities from peak power output to +28 s peak power output. The initial values of the acceleration curve showed a fluctuating decelerating trend of negative values to peak power output; subsequently all values remained positive running along the zero acceleration time axis. Coefficients of correlation between peak power output and power values at -1 s to -3 s were 0.80, 0.65 and 0.63 respectively (p<0.001). The relationship between velocity and acceleration was - 0.968 (p<0.01).
Collapse
Affiliation(s)
- W Bell
- University of Wales, Institute Cardiff, United Kingdom.
| | | |
Collapse
|
5
|
Bell W, Colley JP, Gwynne JR, Glazier P, Evans WD, Darlington SE. ACE ID genotype and leg power in Rugby Union players. J Sports Med Phys Fitness 2010; 50:350-355. [PMID: 20842098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
AIM The present study examined the hypothesis that there were no significant differences between forwards and backs in the elements of leg power between the ID and DD genotypes of the ACE (I/D) gene in developing young adult Rugby Union players. METHODS Sixty-eight players were recruited to identify the distribution of genotypes between forwards and backs. Fifty-eight players were investigated for leg power. Forwards (n=28) comprised 15 ID and 13 DD genotypes, and backs (n=30) 19 ID and 11 DD genotypes. Leg power was measured on a force platform using a counter movement jump; the parameters of interest were peak and relative force, peak and relative power, displacement and velocity. The three-primer polymerase chain reaction was used to assay the region of interest for I and D variants of the ACE gene. The distribution of genotypes was determined by chi-square and comparisons between forwards and backs made using the independent t-test. RESULTS No significant differences were identified in the distribution of genotypes between forwards and backs (χ2=2.2, P=0.336). However, significant differences were identified between forwards and backs in a number of components of leg power. Backs had significantly larger values than forwards for relative force (1.50 vs. 1.30 Wt%, P=0.001) and relative power (27.1 vs. 24.3 W.kg-1, P=0.034) for the ID genotype, whereas backs had significantly larger values than forwards for displacement (0.42 vs. 0.38 m, P=0.049) and velocity (2.76 vs. 2.55 m.s.(-1), P=0.007) for the DD genotype. CONCLUSION The characteristics of leg power identified will enhance the functional requirements of players according to playing position and commitment.
Collapse
Affiliation(s)
- W Bell
- University of Wales, Institute Cardiff, Cyncoed, Cardiff, Wales, UK. wbell@ uwic.ac.uk
| | | | | | | | | | | |
Collapse
|
6
|
Bell W, Warner JT, Evans WD, Webb DKH, Mullen RH, Gregory JW. Perception of effort at low and moderate intensity exercise in survivors of childhood acute lymphoblastic leukaemia. Ann Hum Biol 2009; 33:357-71. [PMID: 17092872 DOI: 10.1080/03014460600687382] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
OBJECTIVE The study examined the degree to which male and female survivors of acute lymphoblastic leukaemia (ALL) perceive effort at low and moderate intensity exercise in association with related physiological variables. MATERIALS AND METHODS Participants were 67 children. Thirty-five (14 boys and 21 girls) were long-time survivors of ALL and 32 (18 boys and 14 girls) were control subjects. The Children's Effort Rating Table (CERT) was used to measure whole-body perceived exertion at low and moderate intensity exercise. Peak oxygen uptake was measured using a motorized treadmill. CERT and physiological data were analysed using 2 x 2 mixed analyses of variance, appropriate t-tests and coefficients of correlation. RESULTS In absolute terms, boys treated for ALL found perception of effort to be more strenuous at both low (3.9 vs. 3.5 units) and moderate (6.1 vs. 5.3 units) intensity exercise than control subjects, although differences were not significant (p > 0.05); girls treated for ALL found perception of effort to be the same as controls at low intensity exercise (3.1 vs. 3.1 units) but slightly higher than controls at moderate intensity exercise (5.6 vs. 5.2 units); neither of these differences were significant (p > 0.05). When CERT values were adjusted for (.-)VO(2) peak (%) and heart rate (HR) peak (%) differences remained non-significant. There were no significant interactions (Intensity x Group) in males, but the interaction for (.-)VO(2) peak (%) was significant in females (p < 0.05). The main effect for Intensity (low and moderate) was significant for all variables in boys and girls (p < 0.0001). The main effect for Group (ALL and controls) identified significantly greater absolute (b.p.m.) and relative (%) HR values in ALL boys at low and moderate intensity exercise. In female ALL and control subjects the interaction (Intensity x Group) distinguished between (.-)VO(2) peak (%) at moderate intensity exercise and HR peak (%) at low and moderate intensity exercise. Coefficients of correlation between perceived effort and (.-)VO(2) peak (%) in boys and girls were low to high (0.28-0.76), and between absolute and relative HR were also low to high (0.33-0.73). There were low correlations between time 'off therapy' and perceived effort, (.-)VO(2) peak (%) and HR peak (%) (-0.003 to -0.49). CONCLUSION It was concluded that perception of effort in survivors of ALL at low and moderate intensity exercise was the same as that of control subjects. Correlations between perceived effort and physiological variables at moderate exercise were low to high, while those between perceived effort and time from treatment were generally weak.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute, Cyncoed, Cardiff, Wales, UK.
| | | | | | | | | | | |
Collapse
|
7
|
Meara RS, Bell W, Chhieng DC, Bean SM. An unusual neck mass clinically mimicking an enlarged supraclavicular lymph node: cytological features of myositis ossificans circumscriptus. Cytopathology 2009; 20:121-6. [DOI: 10.1111/j.1365-2303.2007.00538.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Bell W, Harrison P, Hardy L, Swain A. Book reviews. J Sports Sci 2007. [DOI: 10.1080/02640419208729945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
9
|
Abstract
The objective of the present investigation was to examine a proposal which stated that individual power values should be aligned according to peak power output (PPO) before calculating the mean value of PPO. This procedure removes the variation in time it takes for individuals to reach PPO. Participants were forty-one University Rugby Union Football players of mean age 21.7 +/- 2.6 years, height 181.4 +/- 6.9 cm and body mass 88.9 +/- 12.7 kg. Data were collected using a friction-belt cycle ergometer (Monark 864, Varberg, Sweden). A significantly larger mean value for PPO was found when results were calculated from time-aligned rather than cross-sectional data (1154 +/- 246 vs. 1121 +/- 254 W, p < 0.0001); the mean difference was approximately 3 %. Additionally, the average profile of the power output curve was more reflective of individual power curves. The negative correlation between PPO and the time taken to reach PPO was - 0.32 (p < 0.05), confirming the view that the earlier the time taken to reach PPO the larger the PPO. It was concluded that the mean value of PPO and the corresponding profile for power output curves are best represented by the analysis of time-aligned rather than cross-sectional data.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute-Cardiff, Cyncoed Campus, Cardiff, Wales, UK.
| | | |
Collapse
|
10
|
Kirkwood JM, Kefford R, Logan T, Mainwaring PN, Millward M, Pavlick AC, Dar MM, Kathman S, Laubscher K, Bell W. Phase II trial of iboctadekin (rhIL-18) on a daily X 5 schedule in metastatic melanoma (MM). J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10043 Background: Interleukin-18 (IL-18) is an immunostimulatory cytokine with potent antitumor activity in preclinical models. Two phase I studies of recombinant human (rh) IL-18 explored a wide dose range (0.03–1.0 mg/kg) without reaching a maximum tolerated dose (MTD) on the daily × 5 schedule. Pharmacodynamic data including inflammatory cytokine production and activation of lymphocyte subsets revealed optimal biologic activity at the lower end of the dose range (0.01–0.2 mg/kg) as did 2 unconfirmed partial responses (PRs) in a MM and a renal cancer patient (pt) at 0.1 mg/kg. Methods: An open-label, randomized, phase II trial in 60 adult pts with previously untreated MM was conducted to evaluate the efficacy and safety of rhIL-18 administered as a 2-hour IV infusion daily × 5 every 28 days for 6 cycles. Pts with PS ≤ 1, without known CNS involvement, and with adequate end organ function were randomized in stage 1 to 3 dose levels of IL-18 stratified according to AJCC M stage 1a/b vs. 1c. Two confirmed responses for a given dose level in Stage 1 were required to enroll 20 additional pts/level in Stage 2. The 1° objective was determination of overall response rate (ORR) for each dose level. Progression-free survival (PFS), tolerability, and immunogenicity were 2° endpoints. Results: 64 pts were treated at 3 dose levels. Nine pts remain on study. One pt experienced a confirmed PR. Based on preliminary data, the difference in PFS 6 months (mos) was significant (p=0.03) for 0.01 vs 0.1 mg/kg. Most common toxicities were mild to moderate fever, rigors, chills, n/v, and headache. Anti-IL18 antibody (Ab) development correlated with dose level. No clinically significant adverse events were associated with Ab development. Conclusion: Iboctadekin has an acceptable tolerability profile and has activity in MM but insufficient confirmed responses have been observed at this time to initiate Stage 2. Preliminary PFS 6 months indicates an advantage for pts treated at the lowest dose. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- J. M. Kirkwood
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - R. Kefford
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - T. Logan
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - P. N. Mainwaring
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - M. Millward
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - A. C. Pavlick
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - M. M. Dar
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - S. Kathman
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - K. Laubscher
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| | - W. Bell
- University of Pittsburgh Cancer Institute, Pittsburgh, PA; Westmead Hospital, Westmead, Australia; Indiana University Medical Center, Indianapolis, IN; Mater Adult Hospital, South Brisbane, Australia; Sir Charles Gairdner Hospital, Nedlands, Australia; New York University—Kaplan Cancer Center, New York, NY; GlaxoSmithKline, Research Triangle Park, NC
| |
Collapse
|
11
|
du Bois TM, Deng C, Bell W, Huang XF. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 2006; 139:1397-403. [PMID: 16600514 DOI: 10.1016/j.neuroscience.2006.02.068] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2005] [Revised: 01/30/2006] [Accepted: 02/22/2006] [Indexed: 11/24/2022]
Abstract
The aim of this study was to examine the influence of different fat diets on serotonin receptor and transporter binding. Male Sprague-Dawley rats were fed a diet of either high saturated fat, omega-6 polyunsaturated fatty acid, omega-3 polyunsaturated fatty acid or low fat (control) for eight weeks. Using Beta-Imager quantification techniques, [(3)H]ketanserin, [(3)H]mesulergine and [(3)H]paroxetine binding to serotonin (5-HT)(2A), 5-HT(2C) receptors and 5-HT transporters (5-HTT) was measured throughout the brain in all four groups. All three high fatty acid diets influenced serotonin receptor binding, however the most pronounced effects were that compared with the low fat control group, i) 5-HT(2A) receptor binding was increased in the caudate putamen, but reduced in the mammillary nucleus in high saturated fat and high omega-6 polyunsaturated fatty acid diet groups; ii) 5-HT(2C) receptor binding was reduced in the mamillary nucleus of saturated fat group and reduced in prefrontal cortex of the omega-6 polyunsaturated fatty acid and omega-3 polyunsaturated fatty acid groups; and iii) 5-HTT binding was reduced in the hippocampus in the omega-6 polyunsaturated fatty acid group. Overall, the omega-6 polyunsaturated fatty acid diet exerted the most influence on serotonin receptor and transporter binding. These results may be of importance in relation to neuropsychiatric diseases such as schizophrenia, where associations between altered fatty acid levels and the serotonergic system have been made.
Collapse
Affiliation(s)
- T M du Bois
- Neuroscience Institute for Schizophrenia and Allied Disorders, Neurobiology Research Centre for Metabolic and Psychiatric Disorders, Department of Biomedical Science, University of Wollongong, Wollongong, NSW, Australia.
| | | | | | | |
Collapse
|
12
|
Bell W, Evans WD, Cobner DM, Eston RG. Regional placement of bone mineral mass, fat mass, and lean soft tissue mass in young adult rugby union players. Ergonomics 2005; 48:1462-72. [PMID: 16338713 DOI: 10.1080/00140130500101007] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
The purpose of the present study was to ascertain whether differences existed in the regional placement of bone mineral mass (BMM), fat mass (FM) and lean soft tissue mass (LSTM) between playing units in Rugby Union Football and between players and control subjects. Thirty young adult rugby players and 21 controls participated in the study. Players were assigned to groups as either forwards (n = 15) or backs (n = 15). Control subjects were matched (n = 15) to rugby players using the mean BMI of forwards and backs. BMM, FM and LSTM were measured using dual-energy X-ray absorptiometry. The digital image of each subject was partitioned into regional anatomical segments comprising the head, right and left arms, trunk, and right and left legs. Measurements were summed for the arms and legs respectively. One-way ANOVA was used to differentiate between- and within-groups; Tukey's post-hoc test was applied to identify pairwise differences. The alpha level was set throughout at p = 0.01. Principal components analysis was utilized to contrast the regional segments of each tissue in each of the groups. Forwards exhibited larger absolute (kg) amounts of BMM, FM and LSTM than backs or controls. In relative terms (%) there were no significant differences in BMM(%) between forwards, backs and controls in the arms and legs, but differences did occur between backs and controls at the trunk (2.9 vs. 2.5%). Backs had a significantly larger LSTM(%) than forwards at the arms (84.4 vs. 76.5%), legs (80.0 vs. 71.9%) and trunk (89.2 vs. 79.0%), whereas forwards had a greater FM(%) than backs at the arms (18.7 vs. 10.6%), legs (23.1 vs. 14.7%), and trunk (18.4 vs. 8.0%). The distribution of BMM showed a lower body-upper body contrast in forwards, a trunk-extremity contrast in backs and an arm-lower body contrast in controls. FM exhibited a trunk-extremity contrast in all three groups, while LSTM displayed an arm-lower body contrast in all three groups. It is concluded that there are significant regional tissue differences between forwards and backs, which may be related to playing function, and also differences between rugby players and controls.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute Cardiff, Cyncoed, Cardiff CF23 6XD, UK.
| | | | | | | |
Collapse
|
13
|
Lewis N, Gollob J, Cohen R, Thoreson M, Oei C, Kirby L, Koch K, Thurmond L, Dar M, Bell W. Phase I dose escalation study to assess tolerability and pharmacokinetics of recombinant human IL-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.2591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- N. Lewis
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - J. Gollob
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - R. Cohen
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - M. Thoreson
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - C. Oei
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - L. Kirby
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - K. Koch
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - L. Thurmond
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - M. Dar
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| | - W. Bell
- Fox Chase Cancer Center, Philadelphia, PA; Duke University Medical Center, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC
| |
Collapse
|
14
|
Bell W, Davies JS, Evans WD, Scanlon MF, Mullen R. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: A randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone. Am J Hum Biol 2004; 16:533-43. [PMID: 15368601 DOI: 10.1002/ajhb.20055] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The purpose of the present study was to identify the effect of treatment with recombinant human growth hormone (rhGH) on seven somatic characteristics and eight clinical cardiovascular risk factors. Twenty-seven male and 24 female patients between the ages of 21 and 60 years were examined. The investigation was a double-blind, placebo-controlled study of 12 months duration. Patients were assigned randomly to treatment (T) and placebo (P) groups. In the first 6 months group T received rhGH and group P placebo. In the second 6 months both groups received rhGH. Complete data were available for 23 males and 20 females. Increments were calculated between 6 months -BL (increment 1) and 12-6 months (increment 2) in both T and P groups. Apart from the somatotype, data were analysed with a 2 x 2 mixed analysis of variance (ANOVA) using treatment (rhGH and placebo) and time (increments 1 and 2). Somatotype data were analysed using a 2 x 3 multivariate ANOVA. Three significant interactions were identified in males: waist circumference (P = 0.006), trunk fat (P = 0.0001), and conicity index (P = 0.001). The only significant interaction in females was trunk fat (P = 0.006). In general, treatment and placebo groups responded differently by time and treatment. Responses were similar in males and females. In the first 6 months when group P was on placebo, waist circumference, trunk fat, and conicity index increased slightly; with group T on rhGH somatic variables declined markedly. In the second 6 months when both groups received rhGH there was a marked decline in group P and a continued decline (but less steeply) in group T. In males there were significant decreases in endomorphy in group T and increases in mesomorphy in group P. In females the somatotype remained stable. There were no significant interactions in clinical cardiovascular risk factors in either males or females. Favourable responses occurred in male and female lipid profiles, although these were not significant. It was concluded that in males waist circumference, trunk fat, conicity index, and somatotype responded significantly to treatment with rhGH; in females the only significant response was trunk fat.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute Cardiff, Cyncoed, Cardiff CF23 6XD, Wales, UK.
| | | | | | | | | |
Collapse
|
15
|
Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 2003; 89:155-60. [PMID: 12527665 PMCID: PMC1767543 DOI: 10.1136/heart.89.2.155] [Citation(s) in RCA: 100] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
OBJECTIVE To investigate the effects of a 12 week comprehensive cardiac rehabilitation (CCR) programme on patients who have undergone implantation of an implantable cardioverter-defibrillator (ICD). DESIGN Sixteen patients with ICDs (14 (88%) male, mean (SD) age 58 (10) years, range 34-74 years) were randomised to either attend an individually tailored CCR programme or receive usual care. They then changed to the alternative regimen for a further 12 weeks. Exercise capacity was assessed using a treadmill exercise test at baseline, after usual care, after CCR and 12 weeks after CCR to assess maintenance effects. Hospital anxiety and depression (HAD) scores were recorded at each stage. RESULTS Exercise times (min:s; mean (SD)) increased by 16% from a baseline mean of 9:55 (2:33) to 11:11 (2:17) following attendance at CCR (95% confidence interval (CI) 0:34 to 1:58; p = 0.001). This improvement was maintained 12 weeks after attendance at CCR, at 11:20 (2:17) (p = 1.00). HAD scores for anxiety and depression decreased during CCR from a baseline of 13.4 (3.6) to 8.1 (3.6), 95% CI 3.5 to 7.0 (p < 0.001) and 9.9 (3.4) to 6.7 (2.9), 95% CI 1.9 to 4.4 (p = 0.002), respectively. These improvements were maintained at 12 weeks after CCR. No ventricular arrhythmias or ICD discharges occurred during the exercise components of the CCR. The total number of ventricular arrhythmias and ICD discharges was similar 12 weeks before, during, and 12 weeks after CCR. CONCLUSIONS CCR appears to be safe for patients with ICDs. It can improve exercising ability and lower the levels of psychological distress. A larger multicentre study is recommended to confirm these findings.
Collapse
Affiliation(s)
- A Fitchet
- Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK.
| | | | | | | | | | | |
Collapse
|
16
|
Doherty P, Fitchet A, Bundy C, Bell W, Fitzpatrick A, Garratt C. Comprehensive Cardiac Rehabilitation for Patients with Implanted Cardiac Defibrillators. Physiotherapy 2002. [DOI: 10.1016/s0031-9406(05)60735-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
17
|
Scott G, Deng A, Rodriguez-Burford C, Seiberg M, Han R, Babiarz L, Grizzle W, Bell W, Pentland A. Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 2001; 117:1412-20. [PMID: 11886502 DOI: 10.1046/j.0022-202x.2001.01575.x] [Citation(s) in RCA: 84] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Previous studies have shown that the protease-activated receptor 2 is involved in skin pigmentation through increased phagocytosis of melanosomes by keratinocytes. Ultraviolet irradiation is a potent stimulus for melanosome transfer. We show that protease-activated receptor 2 expression in human skin is upregulated by ultraviolet irradiation. Subjects with skin type I, II, or III were exposed to two or three minimal erythema doses of irradiation from a solar simulator. Biopsies were taken from nonexposed and irradiated skin 24 and 96 h after irradiation and protease-activated receptor 2 expression was detected using immunohistochemical staining. In nonirradiated skin, protease-activated receptor 2 expression was confined to keratinocytes in the lower one-third of the epidermis. After ultraviolet irradiation protease-activated receptor 2 expression was observed in keratinocytes in the upper two-thirds of the epidermis or the entire epidermis at both time points studied. Subjects with skin type I showed delayed upregulation of protease-activated receptor 2 expression, however, compared with subjects with skin types II and III. Irradiated cultured human keratinocytes showed upregulation in protease-activated receptor 2 expression as determined by immunofluorescence microscopy and Western blotting. Cell culture supernatants from irradiated keratinocytes also exhibited a dose-dependent increase in protease-activated receptor-2 cleavage activity. These results suggest an important role for protease-activated receptor-2 in pigmentation in vivo. Differences in protease-activated receptor 2 regulation in type I skin compared with skin types II and III suggest a potential mechanism for differences in tanning in subjects with different skin types.
Collapse
Affiliation(s)
- G Scott
- Department of Dermatology, University of Rochester Medical Center, School of Medicine, Rochester, New York 14642, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
|
19
|
Bell W. Patents in therapeutics. A divisive influence. Can Fam Physician 2001; 47:928-31, 937-41. [PMID: 11398722 PMCID: PMC2018495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
|
20
|
Abstract
The non-motorized treadmill system initially reported by Lakomy in 1984 has been used extensively to assess sprinting performance. However, there has been limited research into the reliability of power output measurement using such systems. The aim of this study was to design a system and protocol capable of measuring treadmill sprinting performance in rugby players and to assess the reliability of this system for measuring power output. Twenty-seven rugby players, all of whom were familiar with treadmill sprinting, performed three maximal 6 s sprints with 2 min recovery between sprints, on two occasions 1 week apart. Both tests were performed on a non-motorized Woodway tramp treadmill, interfaced to a data acquisition system. There were no significant differences (P > 0.05) between power output for repeated trials on the same day (between trials) or for repeated trials on different days (between days). Limits of agreement for maximum average power (the average of 100 readings per second) were 4+/-98 and 30+/-157 W for between trials and between days, respectively. When reported as ratio limits of agreement, these were 1.07 (*/divided 1.12) and 1.03 (*/divided 1.16), respectively. The limits of agreement for maximum instantaneous power (the highest of 100 readings per second) were 51+/-464 and 105+/-588 W for between trials and between days, respectively. When reported as ratio limits of agreement, these were 1.02 (*/divided 1.20) and 1.04 (*/divided 1.21) for between trials and between days, respectively. The coefficients of variation for all measures of power output were less than 9.3%. Hence, the treadmill system and protocol developed in this study provide a reliable measure of power output for rugby players.
Collapse
Affiliation(s)
- R J Tong
- School of Sport, Physical Education and Recreation, University of Wales Institute Cardiff, UK.
| | | | | | | |
Collapse
|
21
|
Bell W, Cobner DM, Evans WD. Prediction and validation of fat-free mass in the lower limbs of young adult male Rugby Union players using dual-energy X-ray absorptiometry as the criterion measure. Ergonomics 2000; 43:1708-1717. [PMID: 11083149 DOI: 10.1080/001401300750004113] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The aim was to derive and cross-validate prediction equations to estimate fat-free mass (FFM) in the lower limbs of young adult male Rugby Union players. Thirty players of mean +/- SD age of 21.1 +/- 2.1 years were recruited. Bone mineral mass, fat mass and lean tissue mass were measured with a Hologic QDR 1000/W whole-body scanner. Anthropometry included circumferences, segmental leg lengths and skinfold thicknesses. Players were divided randomly into prediction (n = 15) and cross-validation (n = 15) samples. Regression equations were derived from the prediction sample and validated on the cross-validation sample. Seven equations were formulated to predict leg FFM. The two equations providing the lowest standard errors of estimate were leg length with circumferences at the knee (0.7262) and calf (0.7382); the multiple correlation was 0.83 in both instances. Cross-validation statistics found no significant differences (p > 0.05) between measured (12.4 +/-1.5 kg) and predicted leg FFM (12.1-12.4 kg). The smallest mean difference was -0.05 kg, the largest 0.26 kg; these were equivalent to -0.4 and 2.1% of the measured leg FFM respectively. Correlations between measured and predicted leg FFM were reasonably high (0.79-0.90, p < 0.001). The ratio limits of agreement confirmed that there was little bias between measured and predicted leg FFM (1.00-1.02) and a good level of agreement (1.12-1.16). Because prediction equations tend to be age, gender and population specific, unless validated for other athletic groups, the present equations should be applied to male Rugby Union players with characteristics similar to those described.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute Cardiff, UK.
| | | | | |
Collapse
|
22
|
Abstract
Dual-energy X-ray absorptiometry was used to analyze the regional tissue distribution of bone mineral mass (BMM), fat mass (FM), and lean tissue mass (LTM) in the arms, trunk, and legs of 23 male growth hormone-deficient (GHD) males. Patients were assigned randomly to treatment (n = 11) and control (n = 12) groups. During the first six months, the treatment group received recombinant growth hormone (rhGH) and the control group placebo. During the second six months, both groups received rhGH. Following treatment there was a trend for BMM to be lost in the arms and legs, with gains at the trunk. Fat mass was lost mainly from the trunk. Proportionally more LTM was distributed to the arms and legs than to the trunk. Treatment was more effective in the first six months than the second. The correlation between the waist-hip ratio and trunk fat was poor, suggesting that its use in patients with GHD may be misleading.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute Cardiff, Cyncoed, UK.
| | | | | | | |
Collapse
|
23
|
Karp WB, Grigsby RK, McSwiggan-Hardin M, Pursley-Crotteau S, Adams LN, Bell W, Stachura ME, Kanto WP. Use of telemedicine for children with special health care needs. Pediatrics 2000; 105:843-7. [PMID: 10742330 DOI: 10.1542/peds.105.4.843] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVE In 1995, the Children's Medical Services (CMS) of the State of Georgia contracted with the Department of Pediatrics of the Medical College of Georgia (MCG) and the MCG Telemedicine Center to develop telemedicine programs to provide subspecialty care for children with special health care needs. This article presents project statistics and results of client evaluation of services, as well as physician faculty attitudes toward telemedicine. DESIGN A demonstration project using telemedicine between a tertiary center and a rural clinic serving children with special health care needs was established. Data were collected and analyzed for December 12, 1995 to May 31, 1997, during which 333 CMS telemedicine consultations were performed. RESULTS Most CMS telemedicine consultations (35%) involved pediatric allergy/immunology. Other subspecialties included pulmonology (29%), neurology (19%), and genetics (16%). Overall, patients were satisfied with the services received. Initially, physician faculty members were generally positive but conservative in their attitudes toward using telemedicine for delivering clinical consultation. After a year's exposure and/or experience with telemedicine, 28% were more positive, 66% were the same, and only 4% were more negative about telemedicine. The more physicians used telemedicine, the more positive they were about it (r =.30). CONCLUSIONS In terms of family attitudes and individual care, telemedicine is an acceptable means of delivering specific pediatric subspecialty consultation services to children with special health care needs, living in rural areas distant to tertiary centers. Telemedicine is more likely to be successful as part of an integrated health services delivery than when it is the sole mode used for delivery of care.
Collapse
Affiliation(s)
- W B Karp
- Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA.
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Chan C, Medina-Franco H, Bell W, Lazenby A, Vickers S. Carcinoid tumor of the hepatic duct presenting as a Klatskin tumor in an adolescent and review of world literature. Hepatogastroenterology 2000; 47:519-21. [PMID: 10791227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
This is a case presentation of a 14-year-old boy with the radiological diagnosis of cholangiocarcinoma occluding the hepatic duct bifurcation. His only symptom at presentation was jaundice and further workup confirmed a mass at the porta hepatis. Surgical treatment resulted in a resection of the hepatic bifurcation tumor with a final pathological diagnosis of a carcinoid tumor of the hepatic duct bifurcation. To our knowledge, this is only the second case presented of a resected carcinoid tumor in adolescence. In this communiqué we present the above case and review of the world literature of biliary neuroendocrine tumors.
Collapse
Affiliation(s)
- C Chan
- Department of General Surgery, University of Alabama, School of Medicine, Birmingham 35294-0007, USA
| | | | | | | | | |
Collapse
|
25
|
Goldman A, Paton-Walsh C, Bell W, Toon GC, Blavier JF, Sen B, Coffey MT, Hannigan JW, Mankin WG. Network for the Detection of Stratospheric Change Fourier transform infrared intercomparison at Table Mountain Facility, November 1996. ACTA ACUST UNITED AC 1999. [DOI: 10.1029/1999jd900879] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
26
|
Bell W, Arm S, Cole D, Yassi A. Misleading information. Can Fam Physician 1999; 45:2038, 2040. [PMID: 10509212 PMCID: PMC2328541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
|
27
|
Abstract
The authors report a 46-year-old father and 17-year-old son who each presented with unilateral central retinal vein occlusion (CRVO) and bilateral abnormalities of retinal vascular perfusion. The son presented with a nonperfused CRVO in the left eye, developed traction-rhegmatogenous retinal detachment treated with vitreous surgery, and developed prolonged arteriovenous filling in the retina of the fellow eye. The father presented with progressive CRVO in the right eye, developed choroido-vitreal neovascularization following laser treatment to create a chorioretinal anastomosis, underwent vitrectomy for retinal detachment and vitreous hemorrhage in that eye, and developed prolonged arm-eye and retinal arteriovenous circulation times in the fellow eye. An extensive evaluation (including hematological studies and imaging of the major vessels of the neck) failed to reveal a predisposing cause in either patient although echocardiography disclosed a mitral valve thrombus in the father. After institution of coumadin therapy, the circulatory parameters in the fellow eye of each patient improved.
Collapse
Affiliation(s)
- N Bhagat
- Department of Ophthalmology, New Jersey Medical School, Newark 07103-2499, USA
| | | | | | | | | | | |
Collapse
|
28
|
Abstract
Central retinal vein occlusion is usually a disease of the elderly and is often associated with systemic vascular disease, e.g., hypertension, diabetes mellitus, arteriosclerotic vascular disease. Younger patients, especially those less than 45 years of age, with retinal vein occlusion should be evaluated carefully for the possibility of an underlying thrombotic tendency. The authors describe the ocular manifestations, pathogenesis, associated conditions, patient evaluation, and treatment of patients with central retinal vein occlusion.
Collapse
Affiliation(s)
- N Bhagat
- Department of Ophthalmology, New Jersey Medical School, Newark 07103-2499, USA
| | | | | | | | | | | |
Collapse
|
29
|
Abstract
Osteoporosis in adult life is associated with a significant morbidity and may be predisposed to by osteopenia and failure to reach peak bone mass in childhood. Children treated for acute lymphoblastic leukemia (ALL) may be at risk of osteopenia as a result of previous therapy or as a consequence of the disease process itself. Dual energy x-ray absorptiometry measurements of bone mineral content (BMC) for the whole body and at the lumbar spine and hip were taken in 35 (14 male) long-term survivors of ALL and compared with results in 20 (10 male) survivors of other malignancies and 31 (17 male) healthy sibling controls. The measured BMC was expressed as a percentage of a predicted value derived from the control group and based on the variables that had influence upon it. BMC (%) was reduced at the spine in the ALL group compared with controls [92.4 (8.0)% versus 100.4 (9.7)%, respectively; p < 0.005] and at the hip compared with both other malignancies and controls [89.0 (11.5)% versus 96.1 (11.7)% and 100.4 (9.2)%, respectively; p < 0.0005]. Increasing length of time off therapy was associated with a significant increase in %BMC at both the spine and the hip. For the spine, this association was significantly different between the ALL group and other malignancies, suggesting that any gain in %BMC after therapy was slower in children treated for ALL. Both exercise capacity and levels of physical activity were correlated with %BMC at the hip (r = 0.44, p < 0.001 and r = 0.29, p < 0.01, respectively). Previous exposure to methotrexate, ifosfamide, and bleomycin was associated with a reduction in %BMC at the spine. Exposure to 6-mercaptopurine and cisplatin was associated with a reduction at the hip. In conclusion, children treated for ALL are osteopenic. The mechanism is probably multifactorial but is partially related to previous chemotherapy, limited exercise capacity, and relative physical inactivity.
Collapse
Affiliation(s)
- J T Warner
- Department of Child Health, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
| | | | | | | | | |
Collapse
|
30
|
Lopez P, Guerrero C, Bell W, Rojas A, Meza L, Pantin C. Unilateral mandibular widening by intraoral distracion osteogenesis. Int J Oral Maxillofac Surg 1999. [DOI: 10.1016/s0901-5027(99)81065-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
31
|
Bell W, Davies JS, Evans WD, Scanlon MF. Strength and its relationship to changes in fat-free mass, total body potassium, total body water and IGF-1 in adults with growth hormone deficiency: effect of treatment with growth hormone. Ann Hum Biol 1999; 26:63-78. [PMID: 9974084 DOI: 10.1080/030144699282985] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
The present investigation examined changes in strength in growth hormone deficient (GHD) adults following treatment with recombinant human growth hormone (rhGH), and assessed their relationship to changes in fat-free mass (FFM), total body potassium (TBK), total body water (TBW), the concentration of TBK and TBW per kg FFM, and insulin like growth factor-1 (IGF-1). The investigation was double-blind and placebo-controlled for a period of 6 months; this was followed by a period of open treatment for a further 6 months. Patients were assigned randomly to experimental (E) and control (C) groups. In the first 6 months group E received rhGH and group C placebo; in the second 6 months both groups received rhGH. Serial data were analysed for 23 males (11 group E, 12 group C) and 20 females (10 group E, 10 group C). Body composition was assessed by dual energy X-ray absorptiometry, TBK and TBW. Muscle strength was recorded for arm flexion, leg extension and hand grip. Significant increases in FFM occurred in the first 6 months in group E (2.3 kg males, 1.4 kg females) and in the second 6 months in group C (2.4 kg males, 1.4 kg females). There was a modest increase in absolute strength with time, although only three increments were significant (knee extension in group E males and arm flexion in groups E and C females), all of which occurred during the 6-12 month period. Allometric scaling did not improve the identification of significant increments of strength. The mean concentrations of TBK (males 57.0-58.6, females 51.4-53.9 mmol) and TBW (males 0.65-0.69, females 0.65-0.68 l) per kg FFM, were significantly smaller at all stages of the trial than the reference values, suggesting that treatment had not fully normalized these variables. Likewise, the relationship between most of the increments of regional and total strength, and the corresponding increments of FFM, were generally poor and not significant. It was concluded that the reduced concentrations of TBK and TBW per kg FFM, which may be the effect of an inappropriate dose regime or mode of delivery, may, in part, contribute to the anomaly between increases in strength and FFM.
Collapse
Affiliation(s)
- W Bell
- University of Wales Institute, Cardiff, UK
| | | | | | | |
Collapse
|
32
|
Bell W, Sun W, Hohmann S, Wera S, Reinders A, De Virgilio C, Wiemken A, Thevelein JM. Composition and functional analysis of the Saccharomyces cerevisiae trehalose synthase complex. J Biol Chem 1998; 273:33311-9. [PMID: 9837904 DOI: 10.1074/jbc.273.50.33311] [Citation(s) in RCA: 167] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
In the yeast Saccharomyces cerevisiae, trehalose-6-phosphate synthase (TPS) and trehalose-6-phosphate phosphatase (TPP), which convert glucose 6-phosphate plus UDP-glucose to trehalose, are part of the trehalose synthase complex. In addition to the TPS1 (previously also called GGS1, CIF1, BYP1, FDP1, GLC6, and TSS1) and TPS2 (also described as HOG2 and PFK3) gene products, this complex also contains a regulatory subunit encoded by TSL1. We have constructed a set of isogenic strains carrying all possible combinations of deletions of these three genes and of TPS3, a homologue of TSL1 identified by systematic sequencing. Deletion of TPS1 totally abolished TPS activity and measurable trehalose, whereas deletion of any of the other genes in most cases reduced both. Similarly, deletion of TPS2 completely abolished TPP activity, and deletion of any of the other genes resulted in a reduction of this activity. Therefore, it appears that all subunits are required for optimal enzymatic activity. Since we observed measurable trehalose in strains lacking all but the TPS1 gene, some phosphatase activity in addition to Tps2 can hydrolyze trehalose 6-phosphate. Deletion of TPS3, in particular in a tsl1Delta background, reduced both TPS and TPP activities and trehalose content. Deletion of TPS2, TSL1, or TPS3 and, in particular, of TSL1 plus TPS3 destabilized the trehalose synthase complex. We conclude that Tps3 is a fourth subunit of the complex with functions partially redundant to those of Tsl1. Among the four genes studied, TPS1 is necessary and sufficient for growth on glucose and fructose. Even when overproduced, none of the other subunits could take over this function of Tps1 despite the homology shared by all four proteins. A portion of Tps1 appears to occur in a form not bound by the complex. Whereas TPS activity in the complex is inhibited by Pi, Pi stimulates the monomeric form of Tps1. We discuss the possible role of differentially regulated Tps1 in a complex-bound or monomeric form in light of the requirement of Tps1 for trehalose production and for growth on glucose and fructose.
Collapse
Affiliation(s)
- W Bell
- Laboratorium voor Moleculaire Celbiologie, Katholieke Universiteit Leuven, Kardinaal Mercierlaan 92, B-3001 Leuven-Heverlee, Flanders, Belgium
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Fraga D, Yano J, Reed MW, Chuang R, Bell W, Van Houten JL, Hinrichsen R. Introducing antisense oligodeoxynucleotides into Paramecium via electroporation. J Eukaryot Microbiol 1998; 45:582-8. [PMID: 9864848 DOI: 10.1111/j.1550-7408.1998.tb04553.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
A method utilizing electroporation to deliver antisense oligodeoxynucleotides into Paramecium tetraurelia has been developed. For these studies antisense oligonucleotides directed to different regions of the calmodulin mRNA were used. It was found that a pulse delivered at 150-250 V (375-625 V/cm field strength) for 3.9-4.2 ms using a 275 microF capacitor with resistance set at 13 Ohms was sufficient to achieve measurable incorporation of fluorescently-labeled oligodeoxynucleotides in up to 95% of the cells treated. Optimal parameters included using oligodeoxynucleotides of at least 12 bases in length with a 3' blocking group at a dose of around 10 microM. In addition, multiple oligodeoxynucleotides directed to the same target mRNA resulted in at least a 10-fold reduction in the dose of oligodeoxynucleotide required to achieve the desired effects. Taken together, these results indicate that the use of antisense oligodeoxynucleotides can be an easy and useful method for linking genes to specific functions in Paramecium tetraurelia. Finally, this report discusses how different 3' blocking groups and the use of combinations of oligodeoxynucleotides directed to different regions of the same target mRNA can help address concerns about specificity.
Collapse
Affiliation(s)
- D Fraga
- Fred Hutchinson Cancer Research Center, Division of Basic Sciences, Seattle, Washington.
| | | | | | | | | | | | | |
Collapse
|
34
|
Bell W, Yassi A, Cole DC. On PMWs and two-stroke engines. Can Fam Physician 1998; 44:1775-7, 1787-90. [PMID: 9789655 PMCID: PMC2277886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
On Saturday, August 24, 1996, a 40-year-old man from Edmonton was riding a personal motorized watercraft (PMW, a Seadoo or Jet Ski type of machine) on Shuswap Lake, in south-central British Columbia. He was approximately 200 m offshore. The man motioned to his sister, who was riding another PMW, to follow him across the lake. She did so, but as the turned her head to check for other boat traffic, her brother suddenly slowed down and her machine rode right up on his back, crushing him against his handlebars. His sister, a nurse, held her brother's head above water until help arrived but, 48 minutes after the moment of impact, he was pronounced dead at the Shuswap Lake General Hospital. He had suffered a ruptured aorta.
Collapse
|
35
|
Abstract
Changes in body composition, in particular the onset of obesity, may result from reductions in total daily energy expenditure (TDEE) as a consequence of relative physical inactivity. Children previously treated for acute lymphoblastic leukemia (ALL) become obese, yet the mechanism remains undefined. TDEE and physical activity levels [PAL = TDEE/basal metabolic rate (BMR)] were measured in 34 long-term survivors of ALL and compared with results from 21 survivors of other malignancies and 32 healthy sibling control subjects using the flex-heart rate technique. Body composition was measured by dual energy x-ray absorptiometry. The median TDEE was reduced in the ALL group (150 kJ x kg d(-1)) compared with other malignancies and controls (207 and 185 kJ x kg d(-1), respectively, p < 0.01). This reduction was accounted for mainly by a relative decrease in the PAL of the ALL group (1.24) compared with both other malignancies and controls (1.58 and 1.47, respectively, p < 0.01). TDEE and PAL were correlated with percentage body fat (r = -0.39, p < 0.001 and r = -0.24, p < 0.05, respectively). Obesity in survivors of ALL may, in part, be explained by a reduction in TDEE as a consequence of reduced PAL. The cause of such reduction is uncertain.
Collapse
Affiliation(s)
- J T Warner
- Department of Child Health, University of Wales College of Medicine, Heath Park, Cardiff, UK
| | | | | | | |
Collapse
|
36
|
Rowland FS, Blake DR, Larsen BR, Lindskog A, Peterson PJ, Williams WP, Wallington TJ, Pilling MJ, Carslaw N, Creasey DJ, Heard DE, Jacobs P, Lee J, Lewis AC, McQuaid JB, Stockwell WR, Frank H, Sacco P, Cocheo V, Lynge E, Andersen A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P, Heikkil P, Hürte LG, Jakobsson R, Lundberg I, Moen B, Partanen T, Riise T, Borowiak A, De Saeger E, Schnitzler KG, Gravenhorst G, Jacobi HW, Moelders S, Lammel G, Busch G, Beese FO, Dentener FJ, Feichter J, Fraedrich K, Roelofs GJ, Friedrich R, Reis S, Voehringer F, Simpson D, Moussiopoulos N, Sahm P, Tourlou PM, Salmons R, Papameletiou D, Maqueda JM, Suhr PB, Bell W, Paton-Walsh C, Woods PT, Partridge RH, Slemr J, Slemr F, Schmidbauer N, Ravishankara AR, Jenkin ME, de Leeuw G, van Eijk AM, Flossmann AI, Wobrock W, Mestayer PG, Tranchant B, Ljungström E, Karlsson R, Larsen SE, Roemer M, Builtjes PJ, Koffi B, Koffi EN, De Saeger E, Ro-Poulsen H, Mikkelsen TN, Hummelshøj P, Hovmand MF, Simoneit BR, van der Meulen A, Meyer MB, Berndt T, Böge O, Stratmann F, Cass GR, Harrison RM, Shi JP, Hoffmann T, Warscheid B, Bandur R, Marggraf U, Nigge W, Kamens R, Jang M, Strommen M, Chien CJ, Leach K, Ammann M, Kalberer M, Arens F, Lavanchy V, Gâggeler HW, Baltensperger U, Davies JA, Cox RA, Alonso SG, Pastor RP, Argüello GA, Willner H, Berndt T, Böge O, Bogillo VI, Pokrovskiy VA, Kuraev OV, Gozhyk PF, Bolzacchini E, Bruschi M, Fantucci P, Meinardi S, Orlandi M, Rindone B, Bolzacchini E, Bohn B, Rindone B, Bruschi M, Zetzsch C, Brussol C, Duane M, Larsen B, Carlier P, Kotzias D, Caracena AB, Aznar AM, Ferradás EG, Christensen CS, Skov H, Hummelshøj P, Jensen NO, Lohse C, Cocheo V, Sacco P, Chatzis C, Cocheo V, Sacco P, Boaretto C, Quaglio F, Zaratin L, Pagani D, Cocheo L, Cocheo V, Asnar AM, Baldan A, Ballesta PP, Boaretto C, Caracena AB, Ferradas EG, Gonzalez-Flesca N, Goelen E, Hansen AB, Sacco P, De Saeger E, Skov H, Consonni V, Gramatica P, Santagostino A, Galvani P, Bolzacchini E, Consonni V, Gramatica P, Todeschini R, Dippel G, Reinhardt H, Zellner R, Dämmer K, Bednarek G, Breil M, Zellner R, Febo A, Allegrini I, Giliberti C, Perrino C, Fogg PG, Geiger H, Barnes I, Becker KH, Maurer T, Geyskens F, Bormans R, Lambrechts M, Goelen E, Giese M, Frank H, Glasius M, Hornung P, Jacobsen JK, Klausen HS, Klitgaard KC, Møller CK, Petersen AP, Petersen LS, Wessel S, Hansen TS, Lohse C, Boaretto E, Heinemeier J, Glasius M, Di Bella D, Lahaniati M, Calogirou A, Jensen NR, Hjorth J, Kotzias D, Larsen BR, Gonzalez-Flesca N, Cicolella A, Bates M, Bastin E, Gurbanov MA, Akhmedly KM, Balayev VS, Haselmann KF, Ketola R, Laturnus F, Lauritsen FR, Grøn C, Herrmann H, Ervens B, Reese A, Umschlag T, Wicktor F, Zellner R, Herrmann H, Umschlag T, Müller K, Bolzacchini E, Meinardi S, Rindone B, Jenkin ME, Hayman GD, Jensen NO, Courtney M, Hummelshøj P, Christensen CS, Larsen BR, Johnson MS, Hegelund F, Nelander B, Kirchner F, Klotz B, Barnes I, Sørensen S, Becker KH, Etzkorn T, Platt U, Wirtz K, Martín-Reviejo M, Laturnus F, Martinez E, Cabañas B, Aranda A, Martín P, Salgado S, Rodriguez D, Masclet P, Jaffrezo JL, Hillamo R, Mellouki A, Le Calvé S, Le Bras G, Moriarty J, O'Donnell S, Wenger J, Sidebottom H, Mingarrol MT, Cosin S, Pastor RP, Alonso SG, Sanz MJ, Bravo I, Gonzalez D, Pérez MA, Mustafaev I, Mammadova S, Noda J, Hallquist M, Langer S, Ljungström E, Nohara K, Kutsuna S, Ibusuki T, Oehme M, Kölliker S, Brombacher S, Merz L, Pastor RP, Alonso SG, Cabezas AQ, Peeters J, Vereecken L, El Yazal J, Pfeffer HU, Breuer L, Platz J, Nielsen OJ, Sehested J, Wallington TJ, Ball JC, Hurley MD, Straccia AM, Schneider WF, Pérez-Casany MP, Nebot-Gil I, Sánchez-Marín J, Putz E, Folberth G, Pfister G, Weissflog L, Elansky NP, Sørensen S, Barnes I, Becker KH, Shao M, Heiden AC, Kley D, Rockel P, Wildt J, Silva GV, Vasconcelos MT, Fernandes EO, Santos AM, Skov H, Hansen A, Løfstrøm P, Lorenzen G, Stabel JR, Wolkoff P, Pedersen T, Strom AB, Skov H, Hertel O, Jensen FP, Hjorth J, Galle B, Wallin S, Theloke J, Libuda HG, Zabel F, Touaty M, Bonsang B, Ullerstam M, Langer S, Ljungström E, Wenger J, Bonard A, Manning M, Nolan S, O'Sullivan N, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Sidebottom H, Chadwick P, O'Leary B, Treacy J, Wolkoff P, Clausen PA, Wilkins CK, Hougaard KS, Nielsen GD, Zilinskis V, Jansons G, Peksens A, Lazdins A, Arinci YV, Erdöl N, Ekinci E, Okutan H, Manlafalioglu I, Bakeas EB, Siskos PA, Viras LG, Smirnioudi VN, Bottenheim JW, Biesenthal T, Gong W, Makar P, Delmas V, Menard T, Tatry V, Moussafir J, Thomas D, Coppalle A, Ellermann T, Hertel O, Skov H, Frohn L, Manscher OH, Friis J, Girgzdiene R, Girgzdys A, Gurevich NA, Gårdfeldt K, Langer S, Hermans C, Vandaele AC, Carleer M, Fally S, Colin R, Bernath PF, Jenouvrier A, Coquart B, Mérienne MF, Hertel O, Frohn L, Skov H, Ellermann T, Huntrieser H, Schlager H, Feigl C, Kemp K, Palmgren F, Kiilsholm S, Rasmussen A, Sørensen JH, Klemm O, Lange H, Larsen RW, Larsen NW, Nicolaisen F, Sørensen GO, Beukes JA, Larsen PB, Jensen SS, Fenger J, de Leeuw G, Kunz G, Cohen L, Schlünzen H, Muller F, Schulz M, Tamm S, Geernaert G, Hertel O, Pedersen B, Geernaert LL, Lund S, Vignati E, Jickells T, Spokes L, Matei C, Jinga OA, Jinga DC, Moliner R, Braekman-Danheux C, Fontana A, Suelves I, Thieman T, Vassilev S, Skov H, Hertel O, Zlatev Z, Brandt J, Bastrup-Birk A, Ellermann T, Frohn L, Vandaele AC, Hermans C, Carleer M, Tsouli A, Colin R, Windsperger AM, Turi K, Dworak O, Zellweger C, Weingartner E, Rüttimann R, Hofer P, Baltensperger U, Ziv A, Iakovleva E, Palmgren F, Berkovicz R, Skov H, Alastuey A, Querol X, Chaves A, Lopez-Soler A, Ruiz C, Andrees JM, Allegrini I, Febo A, Giusto M, Angeloni M, Di Filippo P, D'Innocenzio F, Lepore L, Marconi A, Arshinov MY, Belan BD, Davydov DK, Kovaleskii VK, Plotinov AP, Pokrovskii EV, Sklyadneva TK, Tolmachev GN, Arshinov MY, Belan BD, Sklyadneva TK, Behnke W, Elend M, Krüger U, Zetzsch C, Belan BD, Arshinov MY, Davydov DK, Kovalevskii VK, Plotnikov AP, Pokrovskii EV, Rasskazchikova TM, Sklyadneva TK, Tolmachev GN, Belan BD, Arshinov MY, Simonenkov DV, Tolmachev GN, Bilde M, Aker PM, Börensen C, Kirchner U, Scheer V, Vogt R, Ellermann T, Geernaert LL, Pryor SC, Barthelmie RJ, Feilberg A, Nielsen T, Kamens RM, Freitas MC, Marques AP, Reis MA, Alves LC, Ilyinskikh NN, Ilyinskikh IN, Ilyinskikh EN, Johansen K, Stavnsbjerg P, Gabrielsson P, Bak F, Andersen E, Autrup H, Kamens R, Jang M, Strommen M, Leach K, Kirchner U, Scheer V, Börensen C, Vogt R, Igor K, Svjatoslav G, Anatoliy B, Komov IL, Istchenko AA, Lourenço MG, Mactavish D, Sirois A, Masclet P, Jaffrezo JL, van der Meulen A, Milukaite A, Morkunas V, Jurgutis P, Mikelinskiene A, Nielsen T, Feilberg A, Binderup ML, Pineda M, Palacios JM, Garcia E, Cilleruelo C, Moliner R, Popovitcheva OB, Trukhin ME, Persiantseva NM, Buriko Y, Starik AM, Demirdjian B, Suzanne J, Probst TU, Rietz B, Alfassi ZB, Pokrovskiy VA, Zenobi R, Bogatyr'ov VM, Gun'ko VM, Querol X, Alastuey A, Lopez-Soler A, Mantilla E, Plana F, Artiño B, Rauterberg-Wulff A, Israël GW, Rocha TA, Duarte AC, Röhrl A, Lammel G, Spindler G, Müller K, Herrmann H, Strommen MR, Vignati E, de Leeuw G, Berkowicz R. Abstracts of the 6th FECS Conference 1998 Lectures. Environ Sci Pollut Res Int 1998; 5:119-96. [PMID: 19002640 DOI: 10.1007/bf02986409] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Affiliation(s)
- F S Rowland
- Department of Chemistry, University of California, Irvine, 92697, California, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Grigorenko E, Glazier S, Bell W, Tytell M, Nosel E, Pons T, Deadwyler SA. Changes in glutamate receptor subunit composition in hippocampus and cortex in patients with refractory epilepsy. J Neurol Sci 1997; 153:35-45. [PMID: 9455976 DOI: 10.1016/s0022-510x(97)00180-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
An assessment of glutamate receptor subunit profiles was made in hippocampus and temporal lobe cortex of patients with refractory epilepsy. Molecular biological analyses using reverse transcription reaction (RT) followed by polymerase chain reaction (PCR) revealed changes in the distribution profile of the transcripts of AMPA/KA glutamate receptor subunits in hippocampal and cortical tissue from patients with refractory epilepsy when compared to similar tissue from six human and four non-human primate samples with no history of seizures or seizure medication. A severe mean decrease (38% of control) in mRNA for the GluR1 subunit was found in 400 mm cross-sections of hippocampus from patients with epilepsy. Less severe but significant reductions in that GluR1 subunit expression (54% of control) were exhibited in samples of excised temporal pole cortex from the same subjects. Message for the GluR4 subunit was also significantly decreased in hippocampus (68% of control), but in contrast to GluR1, GluR4 mRNA level was not decreased in temporal cortex. Levels of GluR2 mRNA were not significantly changed in epileptic hippocampal and cortical tissue relative to control samples. Protein levels of the GluR1 and GluR4 subunits quantified by Western blot analysis were also reduced in hippocampal and cortical tissue from epilepsy patients. Two other kainate subunit transcripts, GluR6 and KA1 also showed significant changes compared to non-epileptic tissue (136% and 71% of control, respectively). Results are discussed in terms of possible mechanisms by which protracted seizures could produce selective loss of certain AMPA/KA subunits.
Collapse
Affiliation(s)
- E Grigorenko
- Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1800, USA.
| | | | | | | | | | | | | |
Collapse
|
38
|
Bell W. Taking issue with alternative medicine label. Can J Public Health 1997; 88:336, 345. [PMID: 9401171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
39
|
Daran JM, Bell W, François J. Physiological and morphological effects of genetic alterations leading to a reduced synthesis of UDP-glucose in Saccharomyces cerevisiae. FEMS Microbiol Lett 1997; 153:89-96. [PMID: 9252577 DOI: 10.1111/j.1574-6968.1997.tb10468.x] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Yeast cells lacking UDP-Glc pyrophosphorylase (UGPase) encoded by UGPI are not viable. Two strategies were developed to drastically reduce the intracellular concentration of UDP-Glc in order to study the consequences of this metabolic engineering on physiology and morphology. Firstly, UGP1 was placed under the strongly regulatable THI4 promoter. This resulted in a 95% reduction of UGPase activity in the presence of thiamine. The phenotypic effects of this reduction were slightly stronger than those of glucose on the GALI0/CYC1-UGP1 gene fusion [Daran et al. (1995) Eur. J. Biochem. 230, 520-530]. A further reduction of flux towards UDP-Glc was achieved by deletion of the two phosphoglucomutase genes in the ugp1 conditional strain. The growth of this new mutant strain was hardly affected, while it was extremely sensitive to cell wall interfering drugs. Surprisingly, UDP-Glc levels were reduced only by 5-fold, causing a proportional decrease in both glycogen and beta-glucans. Taken altogether, these results indicate that a few percent of enzymatic activities leading to the formation of UDP-Glc appears sufficient to provide the UDP-Glc demands required for cell viability, and that the loss of function of UGP1 is lethal mainly because of the inability of yeast cells to properly form the cell wall.
Collapse
Affiliation(s)
- J M Daran
- Centre de Bioingenierie Gilberi Durand, UMR-CNRS 5504, Laboratoire associé INRA, Toulouse, France
| | | | | |
Collapse
|
40
|
Ferguson G, Bell W, Coupar PI, Glidewell C. Crystal Engineering Using Trisphenols. Three-Dimensional Hydrogen-Bonding Networks in 1,1,1-Tris(4-hydroxyphenyl)ethane, its Hydrated Adduct with 1,4-Diazabicyclo[2.2.2]octane (1/1/1) and its Adduct with Piperazine (4/3). Acta Crystallogr B Struct Sci 1997. [DOI: 10.1107/s010876819601405x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
In 1,1,1-tris(4-hydroxyphenyl)ethane, C20H18O3 (1), monoclinic la, a = 7.9781 (10), b = 18.558 (3), c = 11.1995 (13) Å, \beta–101.668 (9)°, with Z = 4, each of the hydroxyl groups acts as both a donor and an acceptor of hydrogen bonds of the type O—H...O. The molecules are thus connected into square nets, graph set R^4_4(38), pairs of which are then interwoven; the nets are themselves interconnected by further hydrogen bonds to give a continuous three-dimensional network. In 1,1,1-tris(4-hydroxyphenyl)ethane-l,4-diazabicyclo[2.2.2]octane–water (1/1/1), C20H18O3.C6H12N2.H2O (2), triclinic P\overline 1, a = 10.421 (2), b = 10.734 (2), c = 10.9756 (13) Å, \alpha = 76.645 (12), \beta 74.513 (11), \gamma = 89.305 (13)°, with Z = 2, the water molecules are linked to the trisphenol and the diamine units by O—H...O and O—H...N hydrogen bonds, respectively, to form a linear aggregate. These aggregates are linked into chains by the formation of O—H...N hydrogen bonds between the trisphenol and the neighbouring diamine; however, alongside hydrogen-bond formation between the trisphenol and the diamine, there is also partial transfer of a proton, so that the intra-chain links between trisphenol and diamine units are in fact a mixture of O—H...N and N—H...O hydrogen bonds. These chains in the [101] direction are cross-linked by further O—H...O hydrogen bonds, involving only trisphenol O atoms, which form chains in both the [010] and [001] directions, thus generating a continuous three-dimensional network. Adduct (3), 1,1,1-tris(4-hydroxyphenyl)ethane–piperazine (4/3), (C20H18O3)4.(C4H10N2)3, triclinic P\overline 1, a = 12.5049 (11), b = 12.7046 (10), c = 14.6226 (9) Å, \alpha = 113.738 (6), \beta = 100.839 (6), \gamma = 102.438 (7)°, with Z = 1, has two independent trisphenol molecules in general positions and three independent piperazine molecules lying about centres of inversion. The five independent components of the asymmetric unit are linked together by means of three O—H...N and one O—H...O hydrogen bonds to form an open aggregate containing no hydrogen-bonded rings. These aggregates are connected into three sets of interlinked chains in the [010], [001] and [\overline 110] directions: the [010] and [\overline 110] chains employ only O—H...O hydrogen bonds, while the [001] chains employ both O—H...N and N—H...O hydrogen bonds. Additionally, the inversion symmetry at each piperazine unit gives rise to further interlinks.
Collapse
|
41
|
Abstract
Many long term sequelae result from previous treatment for malignancy in childhood. However, little information exists on cardiopulmonary response and energy expenditure during exercise and their possible associations with excess body fat. Measurements of body composition and exercise capacity both at low intensity and maximal aerobic capacity were made on 56 long term survivors of childhood malignancy (35 survivors of acute lymphoblastic leukaemia (ALL) and 21 survivors of other malignancies) and 32 siblings acting as controls. Female survivors of ALL had significantly greater mean (SD) body fat than survivors of other malignancies and siblings (32.5 (6.4)% v 24.3 (4.4)% and 26.3 (8.5)% respectively, p < 0.005). Energy expenditure at low intensity exercise was reduced in survivors of ALL, and negatively correlated with body fat after controlling for weight (partial r range -0.21 to -0.47, p < 0.05). Stroke volume, measured indirectly, was reduced and heart rate raised in ALL survivors at sub-maximal exercise levels. Peak oxygen consumption was significantly reduced in girls and boys treated for ALL compared with siblings (30.5 v 41.3 ml/kg/min for girls, p < 0.05 and 39.9 v 47.6 ml/kg/min for boys, p < 0.05 respectively). Reduced exercise capacity may account in part for the excess adiposity observed in long term survivors of ALL.
Collapse
Affiliation(s)
- J T Warner
- University of Wales College of Medicine, Heath Park, Cardiff
| | | | | | | |
Collapse
|
42
|
Walsh CP, Bell W, Gardiner T, Swann N, Woods P, Notholt J, Schütt H, Galle B, Arlander W, Mellqvist J. An uncertainty budget for ground-based Fourier transform infrared column measurements of HCl, HF, N2O, and HNO3deduced from results of side-by-side instrument intercomparisons. ACTA ACUST UNITED AC 1997. [DOI: 10.1029/97jd00133] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
43
|
Abstract
Table 1 is a synopsis of the major findings from an extensive literature on the association between human body habitus and coronary heart disease. Whilst some studies have used quite sophisticated laboratory procedures to quantify body fat most have relied upon anthropometric measurements to determine some component of body habitus. Of these, body weight and height are the simplest measurements and are, therefore, well-suited to large-scale prospective studies. Height and weight are highly reproducible measurements, although in the short term, weight can have considerable physiological variation associated with gastric emptying and state of hydration. Less reliable measurements than height and weight are skinfolds and body circumferences, both of which have been used extensively in cross-sectional and prospective analyses. For skinfolds, both the inter and intra-observer variability is affected by the measurement technique, location of the skinfold site, the skinfold caliper used and skinfold compressibility. As measurement error has been shown to be a function of skinfold thickness, accurate and repeatable skinfold measurements are particularly difficult to make in the obese. In these subjects, it is not always possible to locate a specific anatomical bony landmark or to pull a parallel skinfold away from the underlying tissue. Furthermore, in the extremely obese it is sometimes possible for a skinfold to be thicker than the jaws of the currently available commercial calipers. Alternately, body circumferences are obtainable in all subjects and have greater reproducibility than skinfolds. They are, therefore, the preferred method in obese subjects. However, there is considerable work to be done to establish their association with body fatness. The evidence examined in this review suggests that body weight is a poor predictor of coronary heart disease. Some studies have reported no difference in the body weight of coronary heart disease patients compared to subjects free of the disease, others found the body weight of subjects with coronary heart disease to be slightly greater, and one found the body weight of cardiac patients to be less than controls. Height, however, is associated with coronary heart disease in prospective studies with long-term and shorter-term follow-up periods and case-control designs. Fetal, infant and childhood under-nutrition may link shorter adult height and susceptibility to cardiovascular disease. Many researchers have studied the relationship between overweight and coronary heart disease by using a surrogate measurement of body fatness such as relative weight or a weight-for-height index. In general, results produced by these studies suggest weight-for-height indices, particularly the often used body mass index, are not strong predictors of coronary heart disease. Indeed case-control designs have consistently failed to show a relationship between body mass index and coronary heart disease. Inconsistent results from prospective studies, however, are difficult to interpret. To further confuse the situation, the body mass index has been examined in relation to different coronary heart disease end-points and adjusted for different confounding variables. Explaining the inconsistent results on the basis of length of follow-up is also not straightforward. When follow-up periods exceed 20 years, and sample size is small, however, this closer association has not been found, even with a long follow-up period. Whilst some studies have found no association after 15, 13 and 12 years others have reported a relationship after 8.5, 10, 12, 10 and 7 years. The 22 year follow-up evidence from the Framingham Study shows the strongest 'independent' association between body mass index and coronary heart disease. (ABSTRACT TRUNCATED)
Collapse
|
44
|
Kaufman DM, Bell W. Teaching and assessing clinical skills using virtual reality. Stud Health Technol Inform 1997; 39:467-72. [PMID: 10168941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
Abstract
The need to improve the teaching and assessing of students' procedural skills has been well 0 encounters, often with little or no supervision. Assessment of these skills has depended on rudimentary physical models, or standardized patients. The limitations of these methods also are well known. A new technology known as "Virtual Reality" has tremendous potential to assist medical educators in teaching and assessing clinical skills of students, residents and physicians in practice. Virtual Reality consists of a computer-generated three-dimensional simulation in which the user both views and manipulates the contents of the environment. Various degrees of immersion may be experienced that may include elements such as vision, touch or sound. It can provide an environment that so closely represents an actual clinical situation that skills learned will transfer to patients. Many variations in anatomy or other complications can be presented, and trainees can practice hundreds of times until their skills are perfected. This paper describes current activities in this area in the Dalhousie Faculty of Medicine and elsewhere. Various forms of Virtual Reality are described and their application to particular clinical areas are described.
Collapse
Affiliation(s)
- D M Kaufman
- Division of Medical Education, Dalhousie University, Halifax, Nova Scotia, Canada
| | | |
Collapse
|
45
|
|
46
|
Bell W, Ferguson G, Glidewell C. A Paucity of Hydrogen Bonds in Ferrocene-1,1'-diylbis[bis(4-methoxyphenyl)methanol]– Methanol (3/2). Acta Crystallogr C 1996. [DOI: 10.1107/s010827019601075x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
47
|
Schweikhard L, Beiersdorfer P, Bell W, Dietrich G, Krückeberg S, Lützenkirchen K, Obst B, Ziegler J. Production and investigation of multiply charged metal clusters in a Penning trap. ACTA ACUST UNITED AC 1996. [DOI: 10.1007/bf02274913] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Bell W, Coupar PI, Ferguson G, Glidewell C. Multiple Hydrogen Bonds in Pyridine-2,6-dimethanol and Benzene-1,3,5-trimethanol. Acta Crystallogr C 1996. [DOI: 10.1107/s0108270196006014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
49
|
|
50
|
Hale T, Bell W, Mahoney C. Book reviews. J Sports Sci 1996. [DOI: 10.1080/02640419608727722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|